Boyd E. Haley is listed as an executive officer, director, and promoter on 9 SEC Form D filings by 2 issuers between Aug 2011 and Feb 2018: CTI SCIENCE, INC. (Lexington, KY — pharmaceuticals — 2011–2014; $3.7M reported sold to 15 investors) and EMERAMED Ltd (Dublin, Ireland (as filed: L2) — pharmaceuticals — 2014–2018; $3.59M reported sold to 57 investors).
What this means 2 separate companies raised money with this person listed as executive officer, director, and promoter, over about 7 years. Across those companies the filings report $7.29M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 9 public filings for Boyd E. Haley and found 6 differences, 1 worth asking the sponsor about: Form D filed 476 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.